Difference between revisions of "Part:BBa K567015"
Line 2: | Line 2: | ||
<partinfo>BBa_K567015 short</partinfo> | <partinfo>BBa_K567015 short</partinfo> | ||
− | T7 promoter-metG(truncated). This biobrick is constructed by putting the truncated metG ( | + | T7 promoter-''metG''(truncated). This biobrick is constructed by putting the truncated ''metG'' (MetRS) under the control of T7 promoter and lac operator. We have cloned ''metG'' from E.coli and the tRNA recognition domain of MetRS is truncated. KanaR gene with start codon substituted for CGA is used to testify the function of mutated ''metG''. When this biobrick and ''metY''-CGA (BBa_K567016) are co-transformed into the cell, the cells can survive on the LB Kana plate. |
===Construction of BBa_K567015=== | ===Construction of BBa_K567015=== | ||
Line 8: | Line 8: | ||
Rational design of MetRS: we have obtained a truncated MetRS without anticodon recognition domain. The structure of the truncated protein is shown below. This modified MetRS can charge tRNA<sup>Met</sup> without recognizing its anticodon. | Rational design of MetRS: we have obtained a truncated MetRS without anticodon recognition domain. The structure of the truncated protein is shown below. This modified MetRS can charge tRNA<sup>Met</sup> without recognizing its anticodon. | ||
− | [[image:11SJTU-MetRS.jpg|frame|center| | + | [[image:11SJTU-MetRS.jpg|frame|center|Fig. This design is based on the crystal structure of methionyl-tRNA synthetase complex with tRNA (PDB ID:2CSX). We have superimposed the crystal structure of methionyl-tRNA synthetase from ''E.coli'' and obtained the overlay structure after kinetics optimization. Above is the picture showing ''E.coli'' methionyl-tRNA synthetase with (left) and without (right) anticodon recognition domain. The picture proposed that ''E.coli'' methionyl-tRNA synthetase will lose the ability to bind tRNA<sup>Met</sup> anticodon if anticodon recognition domain is deleted, thus losing anticodon specificity while maintaining aminoacylation ability. '''We have built the truncated MetRS, PT7-''metG''N (BBa_K567015), based on this design. ''']] |
Line 15: | Line 15: | ||
When this part, ''metY''-CGA (BBa_K567016) and KanaR (BBa_K567020) are co-transformed into the cell, the cell is expected to survive Kana. We tested the activity of the truncated MetRS PT7-''metG''N (BBa_K567015)and found that the truncated MetRS acted as expected, losing specificity for tRNA<sup>Met</sup> anticodon while maintaining aminoacylation ability. | When this part, ''metY''-CGA (BBa_K567016) and KanaR (BBa_K567020) are co-transformed into the cell, the cell is expected to survive Kana. We tested the activity of the truncated MetRS PT7-''metG''N (BBa_K567015)and found that the truncated MetRS acted as expected, losing specificity for tRNA<sup>Met</sup> anticodon while maintaining aminoacylation ability. | ||
− | [[image:11SJTU-initial_codon_result.jpg|frame|center| | + | [[image:11SJTU-initial_codon_result.jpg|frame|center|Fig. Growth of ER2566 with a. ''metG''N + ''metY''-CGA, b. ''metG''M + ''metY''-CGA, c. + ''metG''N, d. + ''metG''M. Growth medium (left): LB Kana+Tet. Growth medium (right): LB Kana.]] |
Cell growth shows that the cells show Kana resistance only when both modified MetRS (''metG''N) and modified tRNA<sup>Met</sup>(''metY''-CGA) are transformed into the cell, proving that tRNA ''metY''-CGA can transfer fMet to CGA when it is used as the start codon | Cell growth shows that the cells show Kana resistance only when both modified MetRS (''metG''N) and modified tRNA<sup>Met</sup>(''metY''-CGA) are transformed into the cell, proving that tRNA ''metY''-CGA can transfer fMet to CGA when it is used as the start codon |
Revision as of 01:08, 6 October 2011
PT7-metGN
T7 promoter-metG(truncated). This biobrick is constructed by putting the truncated metG (MetRS) under the control of T7 promoter and lac operator. We have cloned metG from E.coli and the tRNA recognition domain of MetRS is truncated. KanaR gene with start codon substituted for CGA is used to testify the function of mutated metG. When this biobrick and metY-CGA (BBa_K567016) are co-transformed into the cell, the cells can survive on the LB Kana plate.
Construction of BBa_K567015
Rational design of MetRS: we have obtained a truncated MetRS without anticodon recognition domain. The structure of the truncated protein is shown below. This modified MetRS can charge tRNAMet without recognizing its anticodon.
Characterization of BBa_K567015
When this part, metY-CGA (BBa_K567016) and KanaR (BBa_K567020) are co-transformed into the cell, the cell is expected to survive Kana. We tested the activity of the truncated MetRS PT7-metGN (BBa_K567015)and found that the truncated MetRS acted as expected, losing specificity for tRNAMet anticodon while maintaining aminoacylation ability.
Cell growth shows that the cells show Kana resistance only when both modified MetRS (metGN) and modified tRNAMet(metY-CGA) are transformed into the cell, proving that tRNA metY-CGA can transfer fMet to CGA when it is used as the start codon
For more information concerning this part, please see [http://2011.igem.org/Team:SJTU-BioX-Shanghai 2011 SJTU-BioX-iGEM]
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal EcoRI site found at 1265
Illegal EcoRI site found at 1437
Illegal XbaI site found at 48 - 12INCOMPATIBLE WITH RFC[12]Illegal EcoRI site found at 1265
Illegal EcoRI site found at 1437
Illegal NheI site found at 1226
Illegal NotI site found at 1290 - 21INCOMPATIBLE WITH RFC[21]Illegal EcoRI site found at 1265
Illegal EcoRI site found at 1437
Illegal BamHI site found at 1259
Illegal XhoI site found at 1211
Illegal XhoI site found at 1299 - 23INCOMPATIBLE WITH RFC[23]Illegal EcoRI site found at 1265
Illegal EcoRI site found at 1437
Illegal XbaI site found at 48 - 25INCOMPATIBLE WITH RFC[25]Illegal EcoRI site found at 1265
Illegal EcoRI site found at 1437
Illegal XbaI site found at 48 - 1000COMPATIBLE WITH RFC[1000]